Repeat Emergency Department Visits Among Patients With Asthma and COPD

• Status: Terminated
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the proposed study is to determine whether the addition of inhaled corticosteroids to treatment with oral corticosteroids and albuterol would reduce repeat emergency department (ED) visits among patients treated for acute exacerbations of asthma and COPD discharged from the emergency department to home. The investigators hypothesize that patients treated with inhaled corticosteroids in addition to oral corticosteroids and albuterol will have lower rates of 30-day return visits to the emergency department than those patients treated with oral corticosteroids and albuterol only.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: State University of New York at Buffalo
• Treatments: Albuterol; Prednisone

Criteria

Inclusion Criteria:

• Treated in the ED at the Erie County Medical Center (ECMC) for acute symptoms of asthma or COPD during the study period

• Patient age ≥ 18 years

• Resident of the City of Buffalo or Erie County

• Discharged to home

• Patient expresses willingness to return to ECMC or own primary care provider for follow-up visits

• Able to provide informed consent

• Able to comprehend English language

Exclusion Criteria:

• Received oral or inhaled corticosteroids in the week before ED presentation

• Presented to the ED primarily for prescription refills

• Complicated comorbid conditions (e.g. renal disease, cardiovascular disease, CHF, HIV)

• Admitted to ECMC or discharged to another facility

• Previously enrolled during a prior visit to the ED during the study period

• For female patients--pregnant or pregnancy status indeterminate

• Antibiotics are prescribed to treat current asthma/COPD exacerbation.